By Sally Robertson, B.Sc. Sep 8 2021 Researchers in Texas have provided evidence for the need to modify the currently used coronavirus disease 2019 (COVID-19) vaccines to match circulating variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The team from the University of Texas Medical Branch in Galveston showed the distinct cross-neutralizing profiles that were...
